Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9032215 | NeuroToxicology | 2005 | 9 Pages |
Abstract
Despite the large body of experimental evidence demonstrating the neuroprotective properties of 17β-estradiol (17β-E2) both in vitro and in vivo experimental models of neuronal injury, the exact mechanisms implicated in neuroprotection have not been fully delineated. Some experimental evidence highlight a role for the antioxidant properties of 17β-E2 in mediating protection against oxidative injury. Parallel to these, evidence also exist which point to alternative mechanisms involving estrogen receptors (ER). The HIV-1 coat protein, gp120, has been implicated in the progression of central nervous system damage caused by HIV-1 infection. The neurotoxic effects induced by gp120 are triggered via an excitotoxic mechanism of cell death which implicates alteration of calcium homeostasis, activation of calcium-dependent pathways, mitochondrial uncoupling and membrane lipid peroxidation. In the present study, we demonstrate that 17β-E2 protects human SH-SY5Y neuroblastoma cells from cell death elicited by gp120. Tamoxifen and ICI 182,780, two ER antagonists, both antagonized 17β-E2-mediated inhibition of cell death. Exposure of SH-SY5Y cells to gp120 for 30 min caused a significant accumulation of intracellular reactive oxygen species (ROS) and this was abrogated by 17β-E2; however, the ability of 17β-E2 to counteract ROS generation induced by gp120 does not account for the reported prevention of cell death because ICI 182,780 failed to revert intracellular ROS reduction caused by 17β-E2 though it was able to revert prevention of cell death. Furthermore, by using 17α-E2, the isomer unable to stimulate ER which, however, retains the antioxidant effects, we observed that a pre-treatment with 17α-E2 was effective in preventing gp120-induced accumulation of ROS but it failed to affect cell death caused by the viral protein. Collectively, these data demonstrate that neuroprotection afforded by 17β-E2 is receptor-mediated and ROS scavenging effects may not be implicated.
Keywords
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Rossella Russo, Michele Navarra, Jessica Maiuolo, Domenicantonio Rotiroti, Giacinto Bagetta, Maria Tiziana Corasaniti,